BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32815874)

  • 1. Outcomes of Febrile Neutropenia in Children With Cancer Managed on an Outpatient Basis: A Report From Tertiary Care Hospital From a Resource-limited Setting.
    Meena JP; Gupta AK; Seth R
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):467-473. PubMed ID: 32815874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial.
    Orme LM; Babl FE; Barnes C; Barnett P; Donath S; Ashley DM
    Pediatr Blood Cancer; 2014 Aug; 61(8):1427-33. PubMed ID: 24604835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].
    Borget I; Antoun S; Chachaty E; Gachot B; Alibay A; Di Palma M; Merad M
    Bull Cancer; 2014 Oct; 101(10):925-31. PubMed ID: 25373692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
    Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
    Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
    Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of step-down to oral outpatient treatment versus inpatient antimicrobial treatment in pediatric cancer patients with febrile neutropenia: A noninferiority multicenter randomized clinical trial.
    Avilés-Robles MJ; Reyes-López A; Otero-Mendoza FJ; Valencia-Garin AU; Peñaloza-González JG; Rosales-Uribe RE; Muñoz-Hernández O; Garduño-Espinosa J; Juárez-Villegas L; Zapata-Tarrés M
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28251. PubMed ID: 32196898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.
    Rivas-Ruiz R; Villasis-Keever M; Miranda-Novales G; Castelán-Martínez OD; Rivas-Contreras S
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009031. PubMed ID: 30887505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia.
    Paolino J; Mariani J; Lucas A; Rupon J; Weinstein H; Abrams A; Friedmann A
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27679. PubMed ID: 30916887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Time to Antibiotics for Pediatric Oncology Patients With Fever and Suspected Neutropenia by Applying Lean Principles.
    Geerlinks AV; Digout C; Bernstein M; Chan A; MacPhee S; Pambrun C; Gallant G; Wyatt L; Fernandez CV; Price VE
    Pediatr Emerg Care; 2020 Nov; 36(11):509-514. PubMed ID: 33125202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of febrile neutropenia in patients receiving chemotherapy for solid tumors: a retrospective study of twenty cases from the radiotherapy centre, Accra, Ghana.
    Vanderpuye V; Yarney J; Beecham K
    West Afr J Med; 2010; 29(5):303-8. PubMed ID: 21089015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
    Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
    Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center.
    Nguyen M; Jacobson T; Torres J; Wann A
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1345. PubMed ID: 33635593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of Levofloxacin Hydrate in Febrile Neutropenia for Outpatient Chemotherapy].
    Inagaki M; Sato J; Nihei S; Kashiwaba M; Kudo K
    Gan To Kagaku Ryoho; 2016 May; 43(5):593-6. PubMed ID: 27210089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study.
    Miedema KG; Tissing WJ; Abbink FC; Ball LM; Michiels EM; van Vliet MJ; de Vries WY; Kamps WA; Norbruis OF; Fiocco M; de Groot-Kruseman HA; van de Wetering MD; de Bont ES
    Eur J Cancer; 2016 Jan; 53():16-24. PubMed ID: 26700076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
    Aquino VM; Herrera L; Sandler ES; Buchanan GR
    Cancer; 2000 Apr; 88(7):1710-4. PubMed ID: 10738231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febrile Neutropenia in Patients with Solid Tumors Undergoing Intravenous Chemotherapy.
    Moreira-Pinto J; Leão I; Palmela C; Branco F; Godinho J; Simões P; Leal-Costa L; Lopes F; Faria A; Casa-Nova M; Escária A; Costa F; Galvão I; Teixeira J; Passos-Coelho JL
    Oncol Res Treat; 2020; 43(11):605-612. PubMed ID: 32818937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fever and neutropenia outcomes and areas for intervention: A report from SUCCOUR - Supportive Care for Children with Cancer in Africa.
    Israels T; Afungchwi GM; Klootwijk L; Njuguna F; Hesseling P; Kouya F; Paintsil V; Landman L; Chitsike I; Chagaluka G; Sung L; Molyneux E
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29224. PubMed ID: 34245212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.